Meet the Expert: BMS – TYK Talk: Discover a New Class of Oral Small Molecules in Development Targeting TYK2

Industry room 1
Meet the Experts
03 June 2021 09:45 - 10:15

Learning Objectives:

  • Discuss the importance of biomarkers in evaluating small oral molecule inhibitors for the treatment of rheumatic diseases such as SLE, CLE, LN, and psoriatic arthritis.
  • Hear key insights and recommendations from experts in the field as they discuss the development of deucravacitinib, a first-in-class oral inhibitor of TYK2.


Title Time Calendar .ics
03 June 2021 09:45 - 10:15 .ics